Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Feedburner
Share Us

Live Webinar Use / Human Factors Engineering to Satisfy the New IEC 62366-1, -2

View: 74

Website https://worldcomplianceseminars.com/webinardetails/368 | Edit Freely

Category

Deadline: June 01, 2018 | Date: June 01, 2018

Venue/Country: Online, U.S.A

Updated: 2018-05-03 21:38:07 (GMT+9)

Call For Papers - CFP

Live Webinar Use / Human Factors Engineering to Satisfy the New IEC 62366-1, -2

Time: 01:00 PM EDT | 10:00 AM PDT | 12:00 PM CDT Duration 90 Minutes

Description

IEC has released a new medical device usability standard, IEC 62366-1:2015 -- Part 1: “Application of the new Usability Engineering Standard to Medical Devices”, and its companion “IEC/TR 62366-2:2016 -- Part 2: Guidance on the application of usability engineering to medical devices” . These addresses an on-going concern by regulatory agencies in both the US and EU, human factors engineering, or it’s synonym, usability engineering. Usability can be defined as “the ability for a human to interact easily and relatively error-free with a system, product or procedure.” The FDA views human factors engineering as mandated to reduce user error and make medical products use as close to intuitive as possible, especially since 2000.

Why should you attend

This webinar will answer basic questions device manufacturers, start-ups, investors and other stakeholders have as to the basic medical device development process incorporating Human Factors / Usability Engineering and its documentation / files, in the U.S. and EU. Meeting regulatory requirements. The integration of the 9 Stages of Use Engineering as well as Product Risk Management (User / Patient) into the Design Control, Design and Development Planning, process, and documentation additions to the DHF / D&DF will be discussed.

Areas Covered

• Key parts of IEC 62366-1, and its implementation

• Part 1, “what”, and Part 2, “how”

• Ties to ISO 14971, Medical Device Risk Management

• Closer adherence to US FDA guidance; more harmonization

• Planning requirements

• The 9-stage engineering process

• Use[r] interface considerations

• Scenarios, Formative and Summative evaluations

• The Usability Engineering File

• Putting it all together – the DHF / D&DF / Technical Documentation.

Who will Benefit

• Senior management

• QA / QAE / RA

• R&D

• Engineering

• Software engineers

• Manufacturing / Operations

• Marketing

• Purchasing

• Consultants

• All others tasked with product development, acquisition and production

Speaker Profile

John E. Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company, with over 32 years experience in U.S. FDA-regulated industries, 18 of which as a full time independent FDA-regulated industry consultant. Mr. Lincoln has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS / CGMP audits and problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He’s held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).

Price: $179 One Dial-in One Attendee | Corporate Live Recorded $279 One Dial In - Max 10 attendees |Group $399 Multiple locations upto 5 dial in | Recorded $249


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.